Page last updated: 2024-12-07

chloramphenicol 3-acetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

chloramphenicol 3-acetate: inactive metabolite of chloramphenicol [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID83940
CHEMBL ID4177469
CHEBI ID16730
SCHEMBL ID4744337
MeSH IDM0087718

Synonyms (18)

Synonym
(2r,3r)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl acetate
CHEBI:16730
10318-16-8
C03601
chloramphenicol 3-acetate
acetic acid [2-(2,2-dichloroacetyl)amino-3-hydroxy-3-(4- nitrophenyl)-propyl] ester
[(2r,3r)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] acetate
3'-o-acetylchloramphenicol
acetamide, n-(1-((acetyloxy)methyl)-2-hydroxy-2-(4-nitrophenyl)ethyl)-2,2-dichloro-, (r-(r*,r*))-
3-acetylchloramphenicol
SCHEMBL4744337
J-000890
chloramphenicol acetate
Q27102050
DTXSID30908222
n-[3-(acetyloxy)-1-hydroxy-1-(4-nitrophenyl)propan-2-yl]-2,2-dichloroethanimidic acid
CHEMBL4177469
3-o-acetylchloramphenicol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
acetate esterAny carboxylic ester where the carboxylic acid component is acetic acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1355412Antimicrobial activity against Escherichia coli ATCC 2452 at 200 ug/ml by Alamar blue based CLSI method2018Journal of natural products, 06-22, Volume: 81, Issue:6
Chloramphenicol Derivatives with Antibacterial Activity Identified by Functional Metagenomics.
AID1355413Antimicrobial activity against Pseudomonas aeruginosa ATCC 2108 at 200 ug/ml by Alamar blue based CLSI method2018Journal of natural products, 06-22, Volume: 81, Issue:6
Chloramphenicol Derivatives with Antibacterial Activity Identified by Functional Metagenomics.
AID1355416Antimycobacterial activity against Mycobacterium tuberculosis ATCC 25177 after 5 days by Alamar blue based CLSI method2018Journal of natural products, 06-22, Volume: 81, Issue:6
Chloramphenicol Derivatives with Antibacterial Activity Identified by Functional Metagenomics.
AID1355414Growth inhibition of Staphylococcus aureus EAMC30 at 62.5 ug/ml by Alamar blue based CLSI method relative to control2018Journal of natural products, 06-22, Volume: 81, Issue:6
Chloramphenicol Derivatives with Antibacterial Activity Identified by Functional Metagenomics.
AID1355415Antimycobacterial activity against Mycobacterium intracellulare ATCC 23068 after 70 to 74 hrs by Alamar blue based CLSI method2018Journal of natural products, 06-22, Volume: 81, Issue:6
Chloramphenicol Derivatives with Antibacterial Activity Identified by Functional Metagenomics.
AID1355411Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 1708 at 200 ug/ml by Alamar blue based CLSI method2018Journal of natural products, 06-22, Volume: 81, Issue:6
Chloramphenicol Derivatives with Antibacterial Activity Identified by Functional Metagenomics.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (25.00)18.7374
1990's1 (12.50)18.2507
2000's4 (50.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.41 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.72 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]